Can medical AI lie? Large study maps how LLMs handle health misinformation / Medical Express
medicalxpress - Medical artificial intelligence (AI) is often described as a way to make patient care safer by helping clinicians manage information. A new study by the Icahn School of Medicine at Mount Sinai and collaborators confronts a critical vulnerability: when a m…
#healthcare #publichealth #governmentpolicy #fda #digitalhealth #medicaldevices
Saturday, February 14, 2026, 3:21 pm / permalink 19202 / 35 stories in 24 days
Physicians are not 'providers': New paper says names in health care have ethical significance / Medical Express
medicalxpress - A new ethics policy paper from the American College of Physicians (ACP) says the term "provider" should not be used to describe physicians, and using the blanket term undermines physicians' ethical responsibility, clinical integrity, and professionalism.
#healthcare #publichealth #governmentpolicy
Saturday, February 14, 2026, 3:21 pm / permalink 19201 / 6 stories in 24 days
Physicians push back on Alabama robotic ultrasound proposal / Beckers
Mariah Taylor / beckershospitalreview - Alabama’s proposal to use robotic ultrasounds to close care gaps is being praised by national leaders but facing pushback from local physicians, KFF Health News reported Feb. 12. Alabama is facing above national average rates for infant mortality on top o…
#healthcare #publichealth #governmentpolicy #infanthealth #digitalhealth #medicaldevices
Saturday, February 14, 2026, 2:21 pm / permalink 19199 / 8 stories in 24 days
Lilly appeals retatrutide classification ruling in case that could impact compounders / Endpoints
Alexis Kramer / endpoints - Eli Lilly is challenging a decision over how the FDA classified its experimental, next-gen obesity shot, in a case that could affect the ability of compounders to rival it. On Thursday, Lilly filed a notice ...
#obesity #healthcare #pharmaceuticals #elililly #weightloss #publichealth #drugdevelopment #fda #digitalhealth
Saturday, February 14, 2026, 12:21 pm / permalink 19191 / 15 stories in 24 days
Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedents / Nature
Abraham Shaked / nature - Nature Medicine, Published online: 09 February 2026; doi:10.1038/s41591-025-04196-3In a study of four brain-dead human decedents, extracorporeal liver cross-circulation using genetically modified pig livers provides essential hepatic functions, supporting…
#healthcare #publichealth #governmentpolicy #biotech #fda #medicaldevices
Saturday, February 14, 2026, 10:21 am / permalink 19188 / 4 stories in 25 days
New FDA-Approved Device Uses Electric Fields to Treat Pancreatic Cancer / Discover
discovermagazine - Learn more about the newly approved wearable treatment that disrupts pancreatic cancer tumor growth while letting patients continue daily life at home.
#healthcare #publichealth #biotech #fda #digitalhealth #medicaldevices #oncology #pancreaticcancer
Saturday, February 14, 2026, 10:21 am / permalink 19187 / 12 stories in 25 days
HPV cancer vaccine slows tumor growth and extends survival in preclinical model / Medical Express
medicalxpress - Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure. After proving this concept across multiple studies, the…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, February 14, 2026, 5:21 am / permalink 19182 / 5 stories in 25 days
Cigna to lay off 2,000 workers worldwide / Healthcare Dive
Rebecca Pifer Parduhn / healthcaredive - Cigna’s layoffs follow other recent downsizing announcements from health insurers looking to cut costs during an era of heightened medical spending.
Saturday, February 14, 2026, 5:21 am / permalink 19181 / 2 stories in 25 days
FDA clears 1st blood test for Alzheimer’s in primary care / Beckers
Ella Jeffries / beckershospitalreview - The first FDA-cleared blood test to assess Alzheimer’s disease in primary care is now available for patients age 55 and older with symptoms of cognitive decline. The test aims to help clinicians rule out Alzheimer’s by identifying individuals unlikely to …
#healthcare #publichealth #governmentpolicy #biotech #fda
Saturday, February 14, 2026, 4:21 am / permalink 19180 / 18 stories in 25 days
Studies test whether gene-editing can fix high cholesterol. For now, take your medicine / Medical Express
medicalxpress - Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol.
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, February 14, 2026, 3:21 am / permalink 19179 / 4 stories in 25 days
Eli Lilly Expands Its In Vivo Ambitions, Acquiring Cell Therapy Startup Orna for up to $2.4B / MedCity
Frank Vinluan / medcitynews - Orna Therapeutics brings Eli Lilly an in vivo cell therapy ready for Phase 1 testing as a potential treatment for autoimmune diseases. Lilly is now the latest pharma company to use M&A to enter this growing field, following deals made in the past year by …
#healthcare #pharmaceuticals #elililly #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment
Saturday, February 14, 2026, 3:21 am / permalink 19178 / 9 stories in 25 days
Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO / Endpoints
Reynald Castañeda / endpoints - Paul Hudson is stepping down from his post as CEO of Sanofi, and his last day will be Feb. 17. The French drugmaker's board decided not to renew Hudson's mandate on ...
#healthcare #pharmaceuticals #biotech #drugdevelopment
Saturday, February 14, 2026, 3:20 am / permalink 19177 / 3 stories in 25 days
FDA to reassess the safety of BHA, a preservative used in popular snack foods / ABC News
go - Federal health officials will reassess the safety of a chemical called BHA used in foods including potato chips, cereals, frozen meals and meat products
#healthcare #publichealth #governmentpolicy #fda #foodsafety
Saturday, February 14, 2026, 1:21 am / permalink 19176 / 4 stories in 25 days
Report reveals a significant global palliative care gap among children / Medical Express
medicalxpress - Nearly all the world's 10.6 million children experiencing serious health-related suffering (SHS) live in low- and middle-income countries with little to no access to palliative care or specialized care for their illness, according to a comprehensive new r…
#healthcare #publichealth #governmentpolicy #infanthealth
Saturday, February 14, 2026, 1:21 am / permalink 19175 / 13 stories in 25 days
Ama launches independent vaccine review after CDC criticism / Medical Express
medicalxpress - Two major medical groups will begin reviewing vaccine safety and effectiveness after major changes at the U.S. Centers for Disease Control and Prevention (CDC) have raised alarms among experts.
#healthcare #pharmaceuticals #publichealth #governmentpolicy #cdc #vaccinesafety
Saturday, February 14, 2026, 12:22 am / permalink 19173 / 4 stories in 25 days
Solace Health Reaches Unicorn Status by Taking the ‘Homework’ Out of Care Navigation / MedCity
Katie Adams / medcitynews - Health advocate network Solace Health gained unicorn status after closing a $130 million Series C funding round. The startup’s advocates help with tasks like scheduling appointments, finding in-network providers, understanding insurance coverage and bills…
Saturday, February 14, 2026, 12:22 am / permalink 19172 / 2 stories in 25 days
BridgeBio Stands Tall as Phase 3 Data Put Dwarfism Drug on Track for FDA Filing / MedCity
Frank Vinluan / medcitynews - Infigratinib achieved statistically significant improvement in growth rate and body composition in a Phase 3 clinical trial that tested the BridgeBio Pharma drug in achondroplasia, the most common form of dwarfism. Regulatory submissions are planned for l…
#healthcare #pharmaceuticals #biotech #drugdevelopment #fda
Saturday, February 14, 2026, 12:22 am / permalink 19171 / 2 stories in 25 days
Talkiatry Rakes In $210M to Scale Virtual Psychiatry Group / MedCity
Katie Adams / medcitynews - Telepsychiatry provider Talkiatry has raised a $210 million Series D round led by Perceptive Advisors, bringing its total funding to more than $400 million. CEO Robert Krayn said the company is focused on scaling its clinician-employed model and improving…
#healthcare #publichealth #digitalhealth
Saturday, February 14, 2026, 12:22 am / permalink 19170 / 3 stories in 25 days
AbbVie sues over selection of Botox for IRA negotiations / Endpoints
Nicole DeFeudis / endpoints - AbbVie is suing CMS for picking Botox for the third round of Medicare negotiations, making it the first drugmaker to challenge the upcoming cycle in court. In a lawsuit filed Wednesday in Washington, DC, AbbVie ...
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy
Saturday, February 14, 2026, 12:22 am / permalink 19169 / 2 stories in 25 days